We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Submits Applications to Expand Nexium Franchise
The item has been added to your shopping cart.
AstraZeneca Submits Applications to Expand Nexium Franchise
May 8, 2009
AstraZeneca has submitted an NDA to the FDA for a product that would allow patients to take low-dose aspirin with a lower risk of gastric or duodenal ulcers.